⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
EYPT News
EyePoint Pharmaceuticals, Inc. Common Stock
Form 8-K
sec.gov
EYPT
EyePoint Announces Third Consecutive Positive DSMC Recommendation for Phase 3 Wet AMD Trials for DURAVYU™, Building Confidence Ahead of Mid-2026 Topline Data
globenewswire.com
EYPT
Prevent Blindness to Host the 2026 ASPECT Patient Engagement Summit and Eyes on Capitol Hill Legislative Advocacy Day in Washington, D.C.
prnewswire.com
GILD
REGN
AMGN
JNJ
MRK
ALKS
APLS
EYPT
OCUL
VRTX
Form 8-K
sec.gov
EYPT
EyePoint Reports First Quarter 2026 Financial Results and Highlights Recent Corporate Developments
globenewswire.com
EYPT
EyePoint to Report First Quarter 2026 Financial Results on May 6, 2026
globenewswire.com
EYPT
EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
globenewswire.com
EYPT
Form 8-K
sec.gov
EYPT
Form 8-K
sec.gov
EYPT
EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
globenewswire.com
EYPT